Speedbul schreef op 24 februari 2020 14:17:
Tweet from Celyad - 20 minutes ago
"Exploiting NK Cell receptors Autologous and Allogeneic CAR-T Cell Therapy"
By Peggy Sotiropoulou, Director R&D at Celyad
Europe CAR-TCR London on Wednesday 26/2/2020 at 12:30 pm GMT